Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia

by | Sep 30, 2026 | Clinical Trials | 0 comments

​ Conditions: Community-acquired Pneumonia; CAP; Community Acquired Pneumonia; Pneumonia; Microbial Composition

Interventions: Drug: Inhaled levofloxacin; Drug: Standard-of-care / Usual care

Sponsors: Copenhagen Respiratory Research

Not yet recruiting Conditions: Community-acquired Pneumonia; CAP; Community Acquired Pneumonia; Pneumonia; Microbial Composition
Interventions: Drug: Inhaled levofloxacin; Drug: Standard-of-care / Usual care
Sponsors: Copenhagen Respiratory Research
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *